BioAge Labs IncBIOA
Price$6.81Intrinsic value$11.9175% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $10.4MTTM through 30 Jun 2026
Net Income -$94.5MTTM through 30 Jun 2026
Free Cash Flow -$88.1MTTM through 30 Jun 2026

Margins

Current
Operating Margin-913.9%
Net Margin-912.3%

Returns

-23.7%ROE
-22.6%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio24.76x
Net Debt-$382Mnet cash position
Cash & Equivalents$74M

Quality Metrics

Altman Z-Score9.32
Piotroski F-Score1 / 9
FCF Margin-850.7%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'24'25
FY2025: $9M
Diluted EPS-$2.39TTM
'23'24'25
FY2025: $-2.24

Dividend

No dividend

Capital Allocation

Capex Intensity4.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.